Therapeutics: Mammalian target of rapamycin (mTOR; FRAP; RAFT1); mTOR complex 1 (mTORC1); mTORC2

Cancer

INDICATION: Breast cancer

In vitro and mouse studies suggest a bivalent compound that inhibits two mTOR domains could help treat breast cancers harboring

Read the full 226 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE